Biocartis

Biocartis, established in 2007, is an innovative molecular diagnostics company focused on automated instruments for detection, data analysis, and reporting. Operating within the Test & Measurement Equipment and Manufacturing sectors, Biocartis provides advanced solutions for the pharmaceutical and healthcare industries. Its flagship idylla™ platform offers molecular diagnostic tests that support critical applications, including cancer testing, enabling precise medical and clinical reporting. The company is dedicated to developing a comprehensive test menu for personalized medicine, aiming for universal access to advanced diagnostics.

With an employee range of 500-1,000 employees, Biocartis maintains a significant operational presence across its 2 locations. Headquartered in Belgium, the company leverages its European base to drive innovation and expand its reach. The team at Biocartis is committed to advancing diagnostic capabilities, and you can Meet Biocartis's team to learn more about their expertise and leadership. Their strategic focus on rapid, reliable testing contributes to improved patient outcomes and supports clinical decision-making in various medical specialties.

Biocartis's proprietary technology is vital for applications such as breast cancer testing and other key assessments, designed for seamless integration into clinical workflows. The company's revenue stands at $53.0M, reflecting its market activity and growth. Biocartis's strategic positioning in Europe, particularly Belgium, facilitates its contribution to the global healthcare landscape by advancing diagnostic technology and enhancing patient care through precise molecular insights.